IRIS
PALUMBO, CARLOTTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.701
AS - Asia 2.305
NA - Nord America 1.482
SA - Sud America 204
AF - Africa 66
OC - Oceania 3
AN - Antartide 1
Totale 6.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.399
SG - Singapore 1.115
RU - Federazione Russa 1.039
IE - Irlanda 757
HK - Hong Kong 382
CN - Cina 337
SE - Svezia 268
VN - Vietnam 214
DE - Germania 197
BR - Brasile 141
FR - Francia 141
IT - Italia 73
GB - Regno Unito 71
IN - India 56
CA - Canada 50
KR - Corea 40
FI - Finlandia 36
BD - Bangladesh 30
BJ - Benin 26
MX - Messico 26
PL - Polonia 25
AR - Argentina 24
UA - Ucraina 22
JP - Giappone 20
IQ - Iraq 18
ID - Indonesia 16
ZA - Sudafrica 16
NL - Olanda 15
TR - Turchia 15
PE - Perù 13
ES - Italia 12
EC - Ecuador 9
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
SA - Arabia Saudita 6
AT - Austria 5
CH - Svizzera 5
IL - Israele 5
TH - Thailandia 5
UZ - Uzbekistan 5
VE - Venezuela 5
BE - Belgio 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DZ - Algeria 3
LV - Lettonia 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
JM - Giamaica 2
KZ - Kazakistan 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MR - Mauritania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SR - Suriname 1
ST - Sao Tome e Principe 1
UY - Uruguay 1
Totale 6.762
Salva come PNG Salva come JPEG
Città #
Dublin 755
Hong Kong 381
Singapore 349
San Jose 275
Ashburn 166
Beijing 158
Lauterbourg 111
Lawrence 107
Princeton 107
Bremen 78
Los Angeles 76
Moscow 71
Ho Chi Minh City 65
Hanoi 46
Santa Clara 39
Seoul 39
Helsinki 34
Buffalo 30
New York 30
Boardman 29
Munich 29
Cotonou 26
São Paulo 23
Warsaw 22
Chennai 20
Orem 18
London 17
Montreal 17
Tokyo 17
Frankfurt am Main 16
Mexico City 16
Toronto 16
Atlanta 12
Boston 12
Brooklyn 12
Chicago 12
Dallas 12
Council Bluffs 11
Lima 11
Amsterdam 10
Ankara 10
Denver 10
Falkenstein 10
Novara 10
Genoa 9
Guangzhou 9
Houston 9
Johannesburg 9
Manchester 9
Mumbai 9
Poplar 9
Baghdad 8
Milan 8
Phoenix 8
Stockholm 8
Dhaka 7
Jacksonville 7
Nuremberg 7
Tianjin 7
Assago 6
Biên Hòa 6
Haiphong 6
Paris 6
Barnet 5
Can Tho 5
Guayaquil 5
Hải Dương 5
Rome 5
San Francisco 5
Tashkent 5
Alessandria 4
Brno 4
Chandler 4
City of London 4
Da Nang 4
Des Moines 4
Hangzhou 4
Kuala Lumpur 4
Lahore 4
Portland 4
Roubaix 4
Seattle 4
Belo Horizonte 3
Berlin 3
Bismarck 3
Brasília 3
Brussels 3
Bucharest 3
Curitiba 3
Erbil 3
Kyiv 3
Miami 3
New Delhi 3
Ottawa 3
Pittsburgh 3
Pune 3
Raleigh 3
Riga 3
Rio de Janeiro 3
San Juan 3
Totale 3.599
Salva come PNG Salva come JPEG
Nome #
Assessment of predictors of renal cell carcinoma progression after nephrectomy at short and intermediate term follow-up and implication on surveillance protocols 115
Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature? 113
Is active surveillance a safe option for small RCCs as it is for small renal masses? 93
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 88
Bone mineral density and frax score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies 85
Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis 84
Bladder tumours in children: An interesting case report of TCC with a partial inverted growth pattern 82
Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma 82
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis 81
Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years 81
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 80
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis: Temporal Trends and Survival Outcomes 78
Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models 77
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 77
Bladder cancer incidence rates and trends in young adults aged 20-39 years 76
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 76
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer 75
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 75
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 73
The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages 73
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality 72
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 71
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: A systematic review 70
Adherence to guideline recommendations for multimodality treatment of patients with pT2–3 M0 non-urothelial carcinoma of the urinary bladder: Temporal trends and survival outcomes 69
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 68
Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group 65
Primary large cell neuroendocrine carcinoma of the renal pelvis: a case report 63
Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer 62
Analysis of circulating tumor cells in prostate cancer patients at psa recurrence and review of the literature 61
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis 60
Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy 60
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study. 59
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) 59
Sex- and age-related differences in the distribution of bladder cancer metastases 59
Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients 58
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 58
Robotic prostatectomy: An update on functional and oncologic outcomes 58
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 57
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 57
Artificial Intelligence in Renal Cell Carcinoma Histopathology: Current Applications and Future Perspectives 56
Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263 56
Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma 56
Survival outcomes of radical prostatectomy vs. external beam radiation therapy in prostate cancer patients with Gleason Score 9-10 at biopsy: A population-based analysis 55
Impact of Obesity on Perioperative Outcomes at Robotic-assisted and Open Radical Prostatectomy: Results From the National Inpatient Sample 55
Concordance between biopsy and radical prostatectomy specimen gleason score in internal and external pathology facilities 55
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology 55
Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities 54
Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration 54
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy 54
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 54
Perineural invasion as a predictor of extraprostatic extension of prostate cancer: A systematic review and meta-analysis 53
Partial nephrectomy in frail patients: Benefits of robot-assisted surgery 53
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy 52
Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis 52
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 52
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data 52
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update 51
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm 50
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma 50
Massive recurring angiomyxoma of the scrotum in a obese man 50
Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group 49
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment Modalities 49
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 49
Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy 49
Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study 49
Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma 49
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder 49
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay 48
Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer 48
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 48
Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study 48
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 48
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 47
The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis 47
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 47
Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: The brescia experience 47
Prostate cancer characteristics and cancer-specific mortality of Native American patients 47
Diagnostic Biopsy for Small Renal Tumours: A Survey of Current European Practice 46
Reply to Wei Qi’s letter to the editor about “Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma” 46
External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients 46
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 46
Preoperative proteinuria correlates with renal function after partial nephrectomy for renal cell carcinoma 45
Conditional survival of patients with stage I–III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 45
Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer 45
Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: A Combined Population-based Analysis 45
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 44
Rates of other-cause mortality after radical cystectomy are decreasing over time—A population-based analysis over two decades 44
Prostate cancer grade and stage misclassification in active surveillance candidates: Black versus white patients 43
The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder 43
Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer 43
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study 43
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 43
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 42
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 42
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients 42
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 42
Racial differences in the distribution of bladder cancer metastases: A population-based analysis 41
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma 41
Trends and social barriers for inpatient palliative care in patients with metastatic bladder cancer receiving critical care therapies 41
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study 41
Totale 5.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/2022134 1 2 1 2 0 0 0 0 5 0 13 110
2022/20231.206 142 70 53 3 80 67 13 75 687 7 7 2
2023/2024458 17 34 40 15 100 0 145 2 3 6 8 88
2024/20251.444 42 3 67 9 26 43 163 86 442 300 21 242
2025/20263.554 203 231 185 349 352 273 613 671 276 401 0 0
Totale 6.812